The potential of drug-carrying immunoliposomes as anticancer agents. Commentary re: J. W. Park et al., Anti-HER2 immunoliposomes: enhanced efficacy due to targeted delivery. Clin. Cancer Res., 8: 1172-1181, 2002.
作者信息
Siwak Doris R, Tari Ana M, Lopez-Berestein Gabriel
机构信息
Department of Bioimmunotherapy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
出版信息
Clin Cancer Res. 2002 Apr;8(4):955-6.
PMID:11948099
Abstract
摘要
Zotero 插件